Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): A case report

Mario Balducci, Berardino De Bari, Stefania Manfrida, Giuseppe Roberto D'Agostino, Vincenzo Valentini

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Aims and background. Merkel cell carcinoma (MCC) is a rare skin tumor occurring mostly in older people. Postoperative radiotherapy is strongly recommended to improve local control. A case of a MCC treated by radiotherapy associated with imiquimod (Aldara) is presented. A possible physiopathological rationale for this concomitant treatment is also given. Materials and methods. We treated a diabetic 82-year-old man presenting with a MCC of the right zygomatic area. Despite surgery, postoperative ultrasonography showed a firm, painless residual mass of about 11 x 10 cm, fixed to the deep tissues. Parotid and zygomatic areas were treated along with the ipsilateral laterocervical lymph nodes. The total dose to the planning target volume was 50.4 Gy (1.8 Gy/day). Imiquimod was applied once a day to the zygomatic area with macroscopic infiltration and to the surrounding erythema. Results. During the combination treatment, the patient showed acute G3 skin toxicity (RTOG) and a scab that resolved after a 3-week interruption of the radiotherapy and imiquimod treatment. When the scab was removed, the underlying skin appeared completely re-epithelialized. Imiquimod was suspended and treatment was continued only with irradiation. During this second phase of the treatment, the patient developed G2 dermatitis and G2 stomatitis. Clinical and instrumental re-evaluation showed a complete response 7 months after the end of radiotherapy, with very good local tropism. Conclusion. This case report suggests the possible effective use of immunomodulators, in this case imiquimod, combined with radiation therapy for cutaneous malignancies such as MCC. Skin tolerance should be an important issue to consider.

Original languageEnglish
Pages (from-to)508-511
Number of pages4
JournalTumori
Volume96
Issue number3
Publication statusPublished - May 2010

Fingerprint

imiquimod
Merkel Cell Carcinoma
Radiotherapy
Skin
Therapeutics
Stomatitis
Tropism
Immunologic Factors
Dermatitis
Erythema
Ultrasonography
Neoplasms
Lymph Nodes

Keywords

  • Imiquimod
  • MCC
  • Merkel cell carcinoma
  • Radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Balducci, M., De Bari, B., Manfrida, S., D'Agostino, G. R., & Valentini, V. (2010). Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): A case report. Tumori, 96(3), 508-511.

Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara) : A case report. / Balducci, Mario; De Bari, Berardino; Manfrida, Stefania; D'Agostino, Giuseppe Roberto; Valentini, Vincenzo.

In: Tumori, Vol. 96, No. 3, 05.2010, p. 508-511.

Research output: Contribution to journalArticle

Balducci, M, De Bari, B, Manfrida, S, D'Agostino, GR & Valentini, V 2010, 'Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): A case report', Tumori, vol. 96, no. 3, pp. 508-511.
Balducci M, De Bari B, Manfrida S, D'Agostino GR, Valentini V. Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): A case report. Tumori. 2010 May;96(3):508-511.
Balducci, Mario ; De Bari, Berardino ; Manfrida, Stefania ; D'Agostino, Giuseppe Roberto ; Valentini, Vincenzo. / Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara) : A case report. In: Tumori. 2010 ; Vol. 96, No. 3. pp. 508-511.
@article{5f3d1489a2c24e7ab781f88507b43962,
title = "Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): A case report",
abstract = "Aims and background. Merkel cell carcinoma (MCC) is a rare skin tumor occurring mostly in older people. Postoperative radiotherapy is strongly recommended to improve local control. A case of a MCC treated by radiotherapy associated with imiquimod (Aldara) is presented. A possible physiopathological rationale for this concomitant treatment is also given. Materials and methods. We treated a diabetic 82-year-old man presenting with a MCC of the right zygomatic area. Despite surgery, postoperative ultrasonography showed a firm, painless residual mass of about 11 x 10 cm, fixed to the deep tissues. Parotid and zygomatic areas were treated along with the ipsilateral laterocervical lymph nodes. The total dose to the planning target volume was 50.4 Gy (1.8 Gy/day). Imiquimod was applied once a day to the zygomatic area with macroscopic infiltration and to the surrounding erythema. Results. During the combination treatment, the patient showed acute G3 skin toxicity (RTOG) and a scab that resolved after a 3-week interruption of the radiotherapy and imiquimod treatment. When the scab was removed, the underlying skin appeared completely re-epithelialized. Imiquimod was suspended and treatment was continued only with irradiation. During this second phase of the treatment, the patient developed G2 dermatitis and G2 stomatitis. Clinical and instrumental re-evaluation showed a complete response 7 months after the end of radiotherapy, with very good local tropism. Conclusion. This case report suggests the possible effective use of immunomodulators, in this case imiquimod, combined with radiation therapy for cutaneous malignancies such as MCC. Skin tolerance should be an important issue to consider.",
keywords = "Imiquimod, MCC, Merkel cell carcinoma, Radiotherapy",
author = "Mario Balducci and {De Bari}, Berardino and Stefania Manfrida and D'Agostino, {Giuseppe Roberto} and Vincenzo Valentini",
year = "2010",
month = "5",
language = "English",
volume = "96",
pages = "508--511",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara)

T2 - A case report

AU - Balducci, Mario

AU - De Bari, Berardino

AU - Manfrida, Stefania

AU - D'Agostino, Giuseppe Roberto

AU - Valentini, Vincenzo

PY - 2010/5

Y1 - 2010/5

N2 - Aims and background. Merkel cell carcinoma (MCC) is a rare skin tumor occurring mostly in older people. Postoperative radiotherapy is strongly recommended to improve local control. A case of a MCC treated by radiotherapy associated with imiquimod (Aldara) is presented. A possible physiopathological rationale for this concomitant treatment is also given. Materials and methods. We treated a diabetic 82-year-old man presenting with a MCC of the right zygomatic area. Despite surgery, postoperative ultrasonography showed a firm, painless residual mass of about 11 x 10 cm, fixed to the deep tissues. Parotid and zygomatic areas were treated along with the ipsilateral laterocervical lymph nodes. The total dose to the planning target volume was 50.4 Gy (1.8 Gy/day). Imiquimod was applied once a day to the zygomatic area with macroscopic infiltration and to the surrounding erythema. Results. During the combination treatment, the patient showed acute G3 skin toxicity (RTOG) and a scab that resolved after a 3-week interruption of the radiotherapy and imiquimod treatment. When the scab was removed, the underlying skin appeared completely re-epithelialized. Imiquimod was suspended and treatment was continued only with irradiation. During this second phase of the treatment, the patient developed G2 dermatitis and G2 stomatitis. Clinical and instrumental re-evaluation showed a complete response 7 months after the end of radiotherapy, with very good local tropism. Conclusion. This case report suggests the possible effective use of immunomodulators, in this case imiquimod, combined with radiation therapy for cutaneous malignancies such as MCC. Skin tolerance should be an important issue to consider.

AB - Aims and background. Merkel cell carcinoma (MCC) is a rare skin tumor occurring mostly in older people. Postoperative radiotherapy is strongly recommended to improve local control. A case of a MCC treated by radiotherapy associated with imiquimod (Aldara) is presented. A possible physiopathological rationale for this concomitant treatment is also given. Materials and methods. We treated a diabetic 82-year-old man presenting with a MCC of the right zygomatic area. Despite surgery, postoperative ultrasonography showed a firm, painless residual mass of about 11 x 10 cm, fixed to the deep tissues. Parotid and zygomatic areas were treated along with the ipsilateral laterocervical lymph nodes. The total dose to the planning target volume was 50.4 Gy (1.8 Gy/day). Imiquimod was applied once a day to the zygomatic area with macroscopic infiltration and to the surrounding erythema. Results. During the combination treatment, the patient showed acute G3 skin toxicity (RTOG) and a scab that resolved after a 3-week interruption of the radiotherapy and imiquimod treatment. When the scab was removed, the underlying skin appeared completely re-epithelialized. Imiquimod was suspended and treatment was continued only with irradiation. During this second phase of the treatment, the patient developed G2 dermatitis and G2 stomatitis. Clinical and instrumental re-evaluation showed a complete response 7 months after the end of radiotherapy, with very good local tropism. Conclusion. This case report suggests the possible effective use of immunomodulators, in this case imiquimod, combined with radiation therapy for cutaneous malignancies such as MCC. Skin tolerance should be an important issue to consider.

KW - Imiquimod

KW - MCC

KW - Merkel cell carcinoma

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=77954991347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954991347&partnerID=8YFLogxK

M3 - Article

C2 - 20845819

AN - SCOPUS:77954991347

VL - 96

SP - 508

EP - 511

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -